Gland Pharma Ltd
NSE:GLAND

Watchlist Manager
Gland Pharma Ltd Logo
Gland Pharma Ltd
NSE:GLAND
Watchlist
Price: 1 755.05 INR -1.79% Market Closed
Market Cap: 289.1B INR
Have any thoughts about
Gland Pharma Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Gland Pharma Ltd

Current Assets 64B
Cash & Short-Term Investments 29.3B
Receivables 14.9B
Other Current Assets 19.8B
Non-Current Assets 44.6B
PP&E 39.3B
Intangibles 3.7B
Other Non-Current Assets 1.6B
Current Liabilities 15.4B
Accounts Payable 10B
Other Current Liabilities 5.4B
Non-Current Liabilities 5.4B
Long-Term Debt 1.3B
Other Non-Current Liabilities 4.1B

Balance Sheet
Gland Pharma Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
3 728
2 364
1 695
4 925
3 158
19 089
3 571
Cash
1 396
1 601
1 395
3 055
2 498
5 462
3 571
Cash Equivalents
2 332
763
300
1 870
660
13 627
0
Short-Term Investments
3 014
5 240
11 708
25 133
29 269
18 539
15 817
Total Receivables
5 276
5 453
6 496
7 479
13 599
11 381
18 908
Accounts Receivables
4 752
5 061
6 018
7 132
12 563
10 242
16 966
Other Receivables
524
392
478
347
1 035
1 139
1 942
Inventory
5 128
9 119
7 563
12 882
12 292
19 782
16 763
Other Current Assets
175
1 399
1 001
818
203
217
1 392
Total Current Assets
17 322
23 575
28 463
51 236
58 521
69 008
56 452
PP&E Net
10 427
10 529
11 566
12 920
16 804
17 361
38 302
PP&E Gross
10 427
10 529
11 566
12 920
16 804
17 361
38 302
Accumulated Depreciation
2 120
2 912
3 797
4 765
5 787
7 231
10 449
Intangible Assets
0
0
0
0
125
117
1 122
Goodwill
0
0
0
0
0
0
2 423
Note Receivable
58
437
421
45
537
855
698
Long-Term Investments
59
64
69
0
0
0
6 545
Other Long-Term Assets
1 430
631
341
759
2 349
435
1 072
Other Assets
0
0
0
0
0
0
2 423
Total Assets
29 295
N/A
35 235
+20%
40 860
+16%
64 961
+59%
78 336
+21%
87 775
+12%
106 612
+21%
Liabilities
Accounts Payable
2 918
4 462
2 491
4 007
4 629
5 874
8 627
Accrued Liabilities
0
0
0
0
0
0
390
Short-Term Debt
0
0
0
0
0
0
1 671
Current Portion of Long-Term Debt
5
6
10
3
3
7
638
Other Current Liabilities
869
860
1 089
1 115
1 189
1 411
2 657
Total Current Liabilities
3 792
5 328
3 590
5 125
5 820
7 291
13 984
Long-Term Debt
66
60
50
47
45
37
1 412
Deferred Income Tax
957
1 076
741
739
878
842
2 201
Other Liabilities
376
152
17
17
17
17
1 777
Total Liabilities
5 191
N/A
6 616
+27%
4 398
-34%
5 928
+35%
6 760
+14%
8 188
+21%
19 374
+137%
Equity
Common Stock
155
155
155
164
164
165
165
Retained Earnings
18 074
22 592
30 487
40 546
52 540
60 235
67 957
Additional Paid In Capital
5 890
5 890
5 890
18 401
18 955
19 284
19 292
Other Equity
15
17
69
78
83
97
176
Total Equity
24 104
N/A
28 620
+19%
36 462
+27%
59 032
+62%
71 576
+21%
79 587
+11%
87 238
+10%
Total Liabilities & Equity
29 295
N/A
35 235
+20%
40 860
+16%
64 961
+59%
78 336
+21%
87 775
+12%
106 612
+21%
Shares Outstanding
Common Shares Outstanding
163
163
163
164
164
165
165

See Also

Discover More